Terminated PHASE2 INTERVENTIONAL NCT00308594

Oral Dexamethasone for the Treatment of Cervical Radiculopathy

Oral Dexamethasone for the Treatment of Cervical Radiculopathy: A Double Blinded, Randomized, Placebo Controlled Trial

Sponsor: University of Manitoba

Updated 5 times since 2017 Last updated: Apr 27, 2011 Started: Nov 30, 2006 Primary completion: Nov 30, 2007 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study terminated due to withdrawl of participating co-investigators.

Other terminated trials from University of Manitoba

See all terminations from University of Manitoba

Other Cervical Radiculopathy trials with similar outcome

NCT03382925 · Phase PHASE4 · Aug 2020

Browse all Cervical Radiculopathy trials

Listed as NCT00308594, this PHASE2 trial focuses on Cervical Radiculopathy and remains terminated or withdrawn. Sponsored by University of Manitoba, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Manitoba

Data source: University of Manitoba

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.